Background and Purpose: Reliable recognition of large vessel occlusion (LVO) on noncontrast computed tomography (NCCT) may accelerate identification of endovascular treatment candidates. We aim to validate a machine learning algorithm (MethinksLVO) to identify LVO on NCCT. Methods: Patients with suspected acute stroke who underwent NCCT and computed tomography angiography (CTA) were included. Software detection of LVO (MethinksLVO) on NCCT was tested against the CTA readings of 2 experienced radiologists (NR-CTA). We used a deep learning algorithm to identify clot signs on NCCT. The software image output trained a binary classifier to determine LVO on NCCT. We studied software accuracy when adding National Institutes of Health Stroke Scale and time from onset to the model (MethinksLVO+). Results: From 1453 patients, 823 (57%) had LVO by NR-CTA. The area under the curve for the identification of LVO with MethinksLVO was 0.87 (sensitivity: 83%, specificity: 71%, positive predictive value: 79%, negative predictive value: 76%) and improved to 0.91 with MethinksLVO+ (sensitivity: 83%, specificity: 85%, positive predictive value: 88%, negative predictive value: 79%). Conclusions: In patients with suspected acute stroke, MethinksLVO software can rapidly and reliably predict LVO. MethinksLVO could reduce the need to perform CTA, generate alarms, and increase the efficiency of patient transfers in stroke networks.
Purpose: To validate a Machine Learning algorithm able to identify LVO on NCCT. Methods: Patients with suspected acute stroke who underwent NCCT+CT Angiography (CTA) from two comprehensive stroke centers were included. Patients with intracranial haemorrhage were excluded. Two experienced radiologists identified the presence of LVO on CTA (NR-CTA) tagging the clot location and manually segmenting the clot. Acute ischemia and clot signs on NCCT were also depicted with assistance of the CTA clot location. With this information a deep learning system was used to create an algorithm (Deepstroke) to identify and locate the presence/absence of acute ischaemia and clot signs in NCCT. Deepstroke image output was used to train a binary classifier to determine LVO on NCCT. Cross-validation was performed in a stratified 5-fold of the data, including deep learning training. We also studied the effect on Deepstroke accuracy when adding the patients NIHSS and time from onset to the model (Deepstroke+). Results: The data cohort included 1354 patients, 724 (53%) with LVO by NR-CTA. The accuracy of Deepstroke to identify LVO had an AUC of 0.81 (sensitivity 0.85; specificity 0.49, PPV 0.66, NPV 0.74), and improved combined with NIHSS and time from symptom onset to AUC 0.88 (sensitivity 0.87, specificity 0.68, PPV 0.76, NPV 0.82). Deepstroke performed better on larger occlusions (Table). Among patients identified as LVO by Deepstroke+ only 19% showed no findings on NR-CTA. The agreement in LVO detection between NR-CTA and Deepstroke+ was 0.78 (Deepstroke was 0.68). Process time per patient was below 120s. Conclusions: In patients with suspected acute stroke, Deepstroke identified LVO in NCCT with a high correlation with radiologist readings of CTAs. Deepstroke could reduce the need to perform CTA, generate alarms and increase the efficiency of patients transfers in the acute management in stroke networks. Deepstroke accuracy will improve as more cases are added to the training set.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.